INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 17 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $55,000 | – | 32,660 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 126,007 | $58,000 | 0.01% |
IMS Capital Management | 20,146 | $9,000 | 0.01% |
EATON VANCE MANAGEMENT | 2 | $0 | 0.00% |
BANK OF AMERICA CORP /DE/ | 70 | $0 | 0.00% |
JANE STREET GROUP, LLC | 46,799 | $21,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 210 | $0 | 0.00% |
NORTHERN TRUST CORP | 70,536 | $32,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
UBS Group AG | 12,659 | $6,000 | 0.00% |
Sugarloaf Wealth Management, LLC | 1 | $0 | 0.00% |